Neurocrine Biosciences, Inc. (NBIX)
Quick facts
| Ticker | NBIX (NASDAQ) |
|---|
Marketed products
- Ingrezza · Neuroscience · revenue 1900
- Ongentys · Metabolic · revenue 200
Ongentys works by blocking the enzyme that breaks down dopamine, allowing more dopamine to be available in the brain. - Crenessity · Nephrology
Crenessity blocks the hormone corticotropin-releasing factor, which stimulates the adrenal glands to produce excess hormones.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: